JPMorgan Chase & Co’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-80,627
Closed -$330K 6199
2022
Q1
$330K Sell
80,627
-40,027
-33% -$164K ﹤0.01% 4204
2021
Q4
$431K Buy
120,654
+27,557
+30% +$98.4K ﹤0.01% 4157
2021
Q3
$339K Sell
93,097
-156,670
-63% -$570K ﹤0.01% 4155
2021
Q2
$1.09M Buy
249,767
+79,970
+47% +$349K ﹤0.01% 3587
2021
Q1
$697K Buy
169,797
+52,092
+44% +$214K ﹤0.01% 3863
2020
Q4
$469K Sell
117,705
-651,395
-85% -$2.6M ﹤0.01% 3785
2020
Q3
$2.08M Sell
769,100
-65,652
-8% -$178K ﹤0.01% 2726
2020
Q2
$2.3M Buy
834,752
+308,354
+59% +$848K ﹤0.01% 2614
2020
Q1
$1.24M Buy
526,398
+470,246
+837% +$1.11M ﹤0.01% 2847
2019
Q4
$264K Buy
56,152
+3,128
+6% +$14.7K ﹤0.01% 3723
2019
Q3
$177K Buy
53,024
+8,600
+19% +$28.7K ﹤0.01% 3799
2019
Q2
$141K Buy
44,424
+9,203
+26% +$29.2K ﹤0.01% 3896
2019
Q1
$107K Sell
35,221
-1,656
-4% -$5.03K ﹤0.01% 3982
2018
Q4
$100K Sell
36,877
-904,240
-96% -$2.45M ﹤0.01% 4046
2018
Q3
$3.16M Buy
941,117
+497,523
+112% +$1.67M ﹤0.01% 2523
2018
Q2
$1.15M Sell
443,594
-5,040
-1% -$13K ﹤0.01% 3078
2018
Q1
$987K Buy
448,634
+377,824
+534% +$831K ﹤0.01% 3090
2017
Q4
$141K Buy
+70,810
New +$141K ﹤0.01% 3782
2017
Q3
Sell
-127,438
Closed -$410K 4493
2017
Q2
$410K Buy
127,438
+93,538
+276% +$301K ﹤0.01% 3217
2017
Q1
$96K Buy
+33,900
New +$96K ﹤0.01% 3744
2016
Q4
Sell
-8,992
Closed -$15K 4586
2016
Q3
$15K Buy
8,992
+3,802
+73% +$6.34K ﹤0.01% 3799
2016
Q2
$5K Buy
+5,190
New +$5K ﹤0.01% 3952
2015
Q3
Sell
-844,100
Closed -$1.76M 3479
2015
Q2
$1.76M Buy
+844,100
New +$1.76M ﹤0.01% 2573
2013
Q4
Sell
-24,659
Closed -$100K 3817
2013
Q3
$100K Sell
24,659
-16,894
-41% -$68.5K ﹤0.01% 3766
2013
Q2
$173K Buy
+41,553
New +$173K ﹤0.01% 3575